INTERNATIONAL PATENT: DAESANG CORPORATION, 대상 주식회사 FILES APPLICATION FOR "GENE VARIANT OF TRANSCRIPTIONAL REGULATOR LYSG AND METHOD FOR PRODUCING L-CITRULLINE OR L-ARGININE USING SAME"

GENEVA, March 3 -- DAESANG CORPORATION (120, Changgyeonggung-roJongno-guSeoul 03130), 대상 주식회사 (서울특별시종로구창경궁로 120) filed a patent application (PCT/KR2025/095018) for "GENE VARIANT OF TRANSCRIPTIONAL REGULATOR LYSG, AND METHOD FOR PRODUCING L-CITRULLINE OR L-ARGININE USING SAME" on Mar 20, 2025. With publication no. WO/2026/043346, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RYU, Mi (178, Magokjun...